Browse all practice questions for the Multiple Sclerosis (MS) Practice Test. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

Multiple Sclerosis (MS) Practice Test course image
All questions

These questions are part of the practice quiz. Start practicing

  • Demyelination in MS primarily affects which tissue?
  • Which cognitive deficit is commonly associated with MS?
  • What MRI finding is classically described as 'Dawson fingers' in MS?
  • Which time window is typically used to demonstrate dissemination in time in McDonald criteria via MRI?
  • Which sequence correctly represents the proposed sequence of events in MS?
  • What does gadolinium enhancement on MRI indicate in MS?
  • Urinary and defecation impairments are not common in MS. True or false?
  • Name an MRI feature that is particularly supportive of MS diagnosis.
  • What is the central histopathologic hallmark of multiple sclerosis plaques?
  • What is the role of MRI in monitoring MS disease activity?
  • What urological symptom is commonly addressed in MS and what management strategies exist?
  • Which symptom describes bladder dysfunction in MS?
  • The precise etiology of MS is ______, but it is widely accepted that MS is an _________ disease.
  • What is a common presenting symptom of optic neuritis in MS?
  • Which mood symptom is commonly observed in MS?
  • Which MRI sequences are most informative for MS evaluation?
  • In McDonald criteria, what demonstrates dissemination in space (DIS)?
  • Which statement best defines Clinically Isolated Syndrome (CIS)?
  • Lymphocytes produce what against oligodendrocytes, contributing to their destruction?
  • Which two diagnostics can support an MS diagnosis?
  • Which statement about serologic testing to differentiate NMOSD and MOGAD is accurate?
  • Most MS patients experience freshness when they wake up, with fatigue by afternoon. Which option best describes this morning state?
  • What type of drugs are used to manage acute MS exacerbations?
  • What is the most common type of pain in MS?
  • Differentiate relapse from pseudo-relapse in MS.
  • Which MS subtype accounts for about 10% of MS cases?
  • What two elements are included in the 2024 McDonald criteria?
  • Damage to the motor cortex and corticospinal tracts in MS may present with which syndrome?
  • What is the typical age range at onset for multiple sclerosis, and what is the female-to-male ratio?
  • Which finding would you expect with pyramidal tract involvement in MS?
  • Which test is used to measure upper-limb function in MS?
  • MS is more common in men.
  • Which sign is commonly seen in MS and involves irregular eye movements?
  • What percent of patients with MS experience spasticity?
  • Which MRI finding indicates active inflammation in MS?
  • Which MS type is more likely to be bed-bound?
  • How long after treating an acute relapse with steroids should one expect clinical improvement?
  • Which spinal cord involvement pattern is typical of MS compared with NMOSD?
  • Which of the following is listed as a disease-modifying agent category in the material?
  • Which factor can contribute to fatigue in MS?
  • What is one limitation of regular exercise for people with MS?
  • Which procedure removes plasma from the blood to treat autoimmune aspects of MS?
  • What are the three steps in a blood cleansing procedure?
  • Optic neuritis is characterized by which of the following?
  • Hyperpathia is best described as?
  • Which test assesses upper-extremity dexterity in MS?
  • Which therapy is a monoclonal antibody that targets alpha-4 integrin?
  • Which of the following is a standard initial approach to managing neurogenic bladder in MS?
  • Which option best demonstrates dissemination in time and space in MS MRI criteria?
  • Which measure is used to assess multiple domains of health-related quality of life in MS, including physical and mental health?
  • What percent of MS cases are relapsing-remitting?
  • Which of the following is a gait symptom seen in MS?
  • What is the typical stance on vitamin D dosing in MS management?
  • What is the epidemiologic relationship between Epstein-Barr virus and MS?
  • What CSF finding from a lumbar puncture supports an MS diagnosis?
  • Which group of viruses has been hypothesized to be involved in multiple sclerosis?
  • Which pharmacologic strategy is commonly used to treat MS-related spasticity?
  • Which test measures endurance and walking capacity in MS?
  • Which of the following describes Primary Progressive MS?
  • What percent of MS patients experience pain and have visual problems?
  • Which nerve is commonly affected by MS, potentially causing visual symptoms?
  • Which test is a widely used balance assessment in MS?
  • Usual onset age for MS?
  • Which aspect best describes the role of rehabilitation therapies in MS care?
  • Which PT implications are important to prevent contracture and disuse atrophy?
  • Which statement best describes MS?
  • Which MS type is most likely to require a cane in a shorter time span compared with relapsing-remitting MS?
  • What term describes scar tissue that forms after MS lesions heal?
  • Trigeminal neuralgia mainly affects which divisions of the trigeminal nerve?
  • Which high-efficacy DMT is associated with infection risk and infusion reactions?
  • What kind of imaging shows segmental demyelination and axonal swelling in acute MS?
  • Is there a single test to confirm a diagnosis of multiple sclerosis?
  • Which type of lymphocytes attack myelin?
  • In spinal MS lesions, what lesion length pattern helps differentiate from NMOSD?
  • Individual MS lesions are called ______, which are replaced by fibrosis (scar tissue).
  • Which advanced MS manifestation involves coordination and balance problems?
  • Which of the following is among the most common motor impairments in MS?
  • Which term describes a gait that is often observed in MS with a wide-based pattern?
  • Which statement about sexual function in multiple sclerosis is correct?
  • Which of the following is NOT typically listed as a cognitive deficit in MS?
  • In CIS patients, what MRI features predict conversion to MS?
  • Which of the following is listed as a disease-modifying agent rather than a general category?
  • Betaseron reduces the severity of which category in MS?
  • Which test measures gait speed over a short distance?
  • What does dysphonia refer to?
  • Which structure is among the most commonly affected by MS?
  • Which test measures endurance by walking for six minutes?
  • Natalizumab is which type of disease-modifying agent used in multiple sclerosis?
  • Which symptom is commonly associated with sclerotic lesions in vestibulocerebellum or central vestibular pathways?
  • Vaccination approach for people with MS on immunomodulatory therapy?
  • MS is the most common cause of chronic neurologic disability in young adults.
  • Which of the following areas is commonly affected by MS?
  • In MS, a larger or flaccid bladder indicates which problem?
  • In McDonald criteria, what demonstrates dissemination in time (DIT) on MRI?
  • Oral medications such as baclofen and diazepam can help treat what MS symptom?
  • What is the most common type of multiple sclerosis?
  • Which statement best describes relapse pattern in Relapsing-Remitting MS?
  • In MRI assessment for MS, what do DIS and DIT stand for?
  • Which measure is a patient-reported scale assessing walking impairment in MS?
  • Which motor symptom is commonly associated with MS and can include muscle stiffness and spasms?
  • Which of the following is an example of an immunomodulation disease-modifying agent?
  • Is it true that more than 50% of MS patients exhibit deficits in cognitive functions?
  • MS destroys oligodendrocytes, leading to which pathology?
  • Dysarthria is defined as
  • Which MS subtype accounts for about 50% of MS cases?
  • What is the main risk factor for progression to PML in natalizumab-treated patients?
  • Which criterion in the McDonald criteria emphasizes the exclusion of other diagnoses?
  • Which MS DMT is approved for PPMS and targets CD20-positive B cells?
  • Nystagmus in MS is caused by disruption of which pathways?
  • Which measure is the MS QOL-54?
  • Which term describes abnormal burning or aching pain in MS?
  • Which gene complex is associated with susceptibility to multiple sclerosis?
  • Which instrument primarily evaluates balance performance in MS?
  • How did McDonald criteria updates influence MS diagnosis timing?
  • Which factors influence the risk of PML in natalizumab-treated patients?
  • What is the standard first-line treatment for an acute MS relapse?
  • What is the role of vitamin D in MS management?
  • In MS, sclerotic plaques refer to which of the following?
  • Which of the following describes the pattern of cognitive impairment commonly seen in MS?
  • A scotoma in MS refers to which of the following?
  • Which optic nerve involvement pattern is more typical of MS than NMOSD?
  • Which condition should be considered when there are longitudinally extensive spinal cord lesions and aquaporin-4 antibodies negative?
  • What is the current standard diagnostic criteria that expanded the role of MRI and CSF biomarkers?
  • Which of the following can exacerbate spasticity?
  • Spasticity in MS is typically more pronounced in the upper extremities than the lower extremities.
  • Name a high-efficacy DMT and summarize a primary safety concern for each.
  • What is the name of the electric shock–like sensation triggered by neck flexion in MS?
  • What is a common cognitive symptom in MS and a typical management approach?
  • Which presenting symptom is most characteristic of optic neuritis in MS?
  • Which statement best describes MS relapse risk during pregnancy and after delivery?
  • Which modality best demonstrates dissemination in the brain and spinal cord for MS?
  • How do clinical features help distinguish MS from NMOSD?
  • Which combination of symptoms is associated with vestibulocerebellar lesions in MS?
  • Name two core immunopathologic processes in MS.
  • Which reflex is affected by CNS lesions leading to bowel movement impairment?
  • Copaxone decreases disability.
  • Name the main MS disease courses and a defining feature of each.
  • What is the typical pattern of corpus callosum or juxtacortical lesions in MS?
  • In multiple sclerosis, Avonex may slow progression of which impairment?
  • Progressive-relapsing MS accounts for what percent of MS cases?
  • Which combination of MRI sequences is most informative for assessing MS burden and activity?
  • In multiple sclerosis, malignant disease is more likely to be which of the following?
  • What is the early hallmark of multiple sclerosis?
  • Which measure is a patient-reported outcome for daily life impact in MS?
  • Which cranial nerves are involved in diplopia commonly seen in MS?
  • Which symptom is NOT caused by bladder-sphincter incoordination?
  • What is Lhermitte's sign and what does it indicate in MS?
  • Which of the following is a clinical manifestation of advanced MS?
  • What type of procedure is used to treat some autoimmune aspects of MS?
  • Which sign is a hallmark of upper motor neuron involvement?
  • How does cladribine function as an MS therapy?
  • Which statement describes the autoimmune aspect of MS?
  • Which DMT is not typically considered a conventional first-line option for RRMS?
  • What is internuclear ophthalmoplegia and its relevance to MS?
  • Which statement about gadolinium in MS MRI is correct?
  • Which MRI measures are commonly used to track long-term disease burden?
  • Is clinical depression common in MS?
  • Which drug is commonly used to manage an acute MS relapse?
  • Which of the following is NOT a typical motor symptom of MS?
  • Which of the following is NOT a cerebellar symptom of MS?
  • Which of the following is a cerebellar symptom of MS?
  • What percentage of MS patients experience trigeminal neuralgia?
  • Elevated levels of which primary protein component in myelin indicate active demyelination?
  • Which instrument includes multiple MS-specific domains including energy and social function?
  • Dysphagia refers to which problem?
  • Which of the following is NOT typically considered a cognitive domain affected in MS?
  • Which spinal cord feature is more characteristic of NMOSD than MS?
  • Which of the following best defines dysarthria in MS?
  • Which of the following is a common visual disturbance associated with multiple sclerosis?
  • Which statement is NOT listed among common cognitive deficits in MS?
  • What CSF finding is supportive of MS?
  • Spasticity can cause which of the following?
  • Two sensory manifestations of MS include altered vibration and position sense; what tract is affected?
  • Impaired gait is commonly observed in MS. Which option best describes this symptom?
  • Which medication is commonly used as an acute relapse treatment in MS?
  • Which urinary symptom is commonly seen in MS due to bladder-sphincter discoordination?
  • Which measure is the MS Impact Scale?
  • How do lymphocytes and monocytes contribute to causing MS?
  • Which MRI feature reflects active disease in MS?
  • Which MS subtype is described as progressive disease from onset but without clear acute relapses that may or may not resolve?
  • Which antibody is associated with MOGAD?
  • Define Uhthoff's phenomenon.
  • In MS, oligoclonal bands are typically found in CSF but not in serum. Which option reflects this pattern?
  • What is the mechanism of action of B-cell-depleting therapies in MS?
  • Chronic neuropathic pain can result from demyelinating lesions in which tracts?
  • What is the mechanism of action of ocrelizumab?
  • Which of the following is a gait and mobility symptom in MS?
  • What are the three internal characteristics of MS?
  • In NMOSD, which biomarker is commonly positive and helps distinguish from MS?
  • Which type of pain is MS often characterized by?
  • When is plasmapheresis indicated in MS?
  • What percent of MS cases are primary progressive?
  • In MS, sclerosis means fibrous tissue formed due to inflammation.
  • What is the chronic inflammatory demyelinating disorder of the CNS commonly known as?
  • Name two common cognitive or psychological symptoms in MS.
  • Which of the following can help reduce fatigue?
  • In the proposed sequence of MS pathology, axonal injury occurs after demyelination.
  • Which statement about symptom management agents is correct?
  • Which antibody is commonly associated with NMOSD?
  • Which MS subtype is the transitional form between relapsing-remitting and progressive disease, accounting for about 50% of cases?
  • How does MS initially present?
  • Which measure is used to assess fine motor dexterity of the hands?
  • What are pseudo-relapses in MS, and how can they be distinguished from true relapses?
  • What is the role of rehabilitation in MS care?
  • Which type of training is generally well tolerated for those with MS?
  • Which factor is NOT associated with increased PML risk in natalizumab-treated patients?
  • Secondary progressive MS is described as which of the following?
  • Why do MS patients need to frequently change bed positioning in advanced stages?
  • Vertigo, dysphagia, and dysarthria are common manifestations of which structure in multiple sclerosis?
  • What is a common non-pharmacologic strategy to manage fatigue in MS?
  • In MS, a small or spastic bladder indicates which problem?
  • Why is it called multiple sclerosis?
  • What is the postpartum period in MS associated with regarding relapse risk?
  • Which imaging modality best shows MS plaques?
  • What are the two main types of medical management agents in MS?
  • Damage to the DCML pathway reduces sensation of?
  • Relapsing-remitting MS is defined by which pattern?
  • Which antibodies help distinguish MS from NMOSD and MOGAD?
  • Which of the following sets lists conventional first-line disease-modifying therapies for RRMS?
  • Which CSF finding is typical in MS?
  • What are sclerotic plaques?
  • The 12 item MS Walking Scale is used to gauge what aspect?
  • What is a typical initial clinical presentation pattern in MS?
  • Which of the following is an immunomodulation disease-modifying agent listed?
  • Demyelinating lesions in the cerebellum and cerebellar tracts are common in MS.
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy